Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA184550
Max Phase: Preclinical
Molecular Formula: C24H32N4O3
Molecular Weight: 424.55
Molecule Type: Small molecule
Associated Items:
ID: ALA184550
Max Phase: Preclinical
Molecular Formula: C24H32N4O3
Molecular Weight: 424.55
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCO/N=C/c1cc(C)c(OCCCCCN2CCN(c3ccncc3)C2=O)c(C)c1
Standard InChI: InChI=1S/C24H32N4O3/c1-4-31-26-18-21-16-19(2)23(20(3)17-21)30-15-7-5-6-12-27-13-14-28(24(27)29)22-8-10-25-11-9-22/h8-11,16-18H,4-7,12-15H2,1-3H3/b26-18+
Standard InChI Key: YZVDVFGPNWREOH-NLRVBDNBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 424.55 | Molecular Weight (Monoisotopic): 424.2474 | AlogP: 4.56 | #Rotatable Bonds: 11 |
Polar Surface Area: 67.26 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.59 | CX LogP: 3.95 | CX LogD: 3.95 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.30 | Np Likeness Score: -1.31 |
1. Chern JH, Lee CC, Chang CS, Lee YC, Tai CL, Lin YT, Shia KS, Lee CY, Shih SR.. (2004) Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones., 14 (20): [PMID:15380197] [10.1016/j.bmcl.2004.07.084] |
Source(1):